{"disease":{"id":"ataxia","name":"ataxia"},"drugs":{"marketed":[{"drug_id":"omaveloxolone","indication_name":"Friedreich’s ataxia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Skyclarys","generic_name":"OMAVELOXOLONE","company_name":"Biogen Us","drug_phase":"marketed","molecular_target":"Nuclear factor erythroid 2-related factor 2","drug_class":"","quality_score":55,"revenue":"300","mechanism":"Skyclarys works by activating the Nrf2 pathway to increase the production of antioxidant proteins that protect cells from damage."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT07092358","title":"Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05034172","title":"Biomarker Research in Inherited Movement Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06016946","title":"Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Friedreich's Ataxia Research Alliance","has_results":false},{"nct_id":"NCT03090789","title":"FA Clinical Outcome Measures","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Friedreich's Ataxia Research Alliance","has_results":false},{"nct_id":"NCT03972202","title":"The Role of Cerebellum in Speech","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":660,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03722212","title":"Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test","phase":"NA","overall_status":"COMPLETED","enrollment_count":636,"lead_sponsor_name":"METAFORA biosystems","has_results":false},{"nct_id":"NCT06628934","title":"Wearable Gait Sensors","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06585605","title":"A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT05160870","title":"Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05160883","title":"Neuroimaging Changes in Hereditary Ataxia","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03336008","title":"Hong Kong Spinocerebellar Ataxias Registry","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06472557","title":"Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT06958341","title":"Neuroimmunology Registry and Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT03869879","title":"Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT03269201","title":"Brain Network Activation in Patients With Movement Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06623890","title":"A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT06953583","title":"A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":255,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04037189","title":"Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT04231487","title":"Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT06593951","title":"Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT03487367","title":"Clinical Trial Readiness for SCA1 and SCA3","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false},{"nct_id":"NCT05943002","title":"Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"German Center for Neurodegenerative Diseases (DZNE)","has_results":false},{"nct_id":"NCT04991701","title":"A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":178,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT02255435","title":"A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05557786","title":"Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia","phase":"NA","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT03286686","title":"Sensori-motor and Perceptual Functions of the PPC.","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07099651","title":"Autosomal Dominant Spinocerebellar Ataxias and Social Cognition","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04106596","title":"HLA Analysis in Autoimmune Encephalitis and Related Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05998473","title":"Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Henri Mondor University Hospital","has_results":false},{"nct_id":"NCT04099914","title":"Validation of a Clinical Algorithm for the Diagnosis of Recessive Ataxias","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04577352","title":"A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT06363058","title":"Electrical Stimulation Cycling Training Effects on SCA","phase":"NA","overall_status":"RECRUITING","enrollment_count":145,"lead_sponsor_name":"Chang Gung University","has_results":false},{"nct_id":"NCT04714307","title":"Neuropsychiatry and Cognition in SCA3/MJD","phase":"","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false},{"nct_id":"NCT02960893","title":"Trial in Adult Participants With Spinocerebellar Ataxia (SCA)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07499999","title":"Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05515536","title":"A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":130,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT04268147","title":"Instrumented Data Exchange for Ataxia Study","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06573866","title":"Enhancement of Quality of Work And Life","phase":"NA","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04346238","title":"Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT02566759","title":"A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":110,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true},{"nct_id":"NCT06605612","title":"Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":108,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT03418740","title":"Neurology Measures in FA Children","phase":"","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT06193200","title":"Evaluate the Neurological Effects of EryDex on Subjects With A-T","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT03563053","title":"Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":104,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":true},{"nct_id":"NCT06664853","title":"Open-Label Extension of EryDex Study IEDAT-04-2022","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":101,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT04495426","title":"Genetic Mechanism of Conserved Ancestral Haplotype in SCA10","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}